Physician profile
Mark D Aierstok
NPI 1881677417
$2,059.07
in general payments reported to CMS, 2019-2025
10 companies · $420 in 2025
The $420 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.07 · 2020: $66.51 · 2021: $1,294 · 2022: $57.81 · 2024: $145 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $1,254.46 | 2021 | |
| Stryker Corporation | $438.54 | 2024-2025 | Mako |
| Pacira Therapeutics, INC. | $71.38 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $70.36 | 2020-2022 | |
| Depuy Synthes Sales INC. | $68.12 | 2025 | Velys |
| Medtronic, INC. | $60.59 | 2022-2025 | Kyphon Express II Kyphopak Tray |
| Djo, LLC | $36.73 | 2025 | Cmf |
| Sanofi-Aventis U.S. LLC | $25.84 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.40 | 2019 | |
| Smith+Nephew, INC. | $15.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Aierstok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.